Although dexamethasone may be a beneficial adjunct to surgery in terms of its antiemetic and anti-inflammatory effects, a team of researchers from Thomas Jefferson University Hospital has found that it may have a darker side, particularly in patients with diabetes.
Their pilot study concluded that dexamethasone administration was associated with significant postoperative hyperglycemia in these patients when undergoing functional endoscopic sinus surgery (FESS), which ultimately may lead to